VivoSim Labs, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| CROUCH TAYLOR | CEO & President | Tax Withholding | 5,140 | $1.07 | $5,500 | 164,544 | Nov 16, 2018 |
| Bush Jennifer | General Counsel & Secretary | Tax Withholding | 11,915 | $1.07 | $12,749 | 281,588 | Nov 16, 2018 |
| Presnell Sharon Collins | Chief Scientific Officer | Sale | 40,000 | $1.27 | $50,800 | 292,193 | Nov 8, 2018 |
| Presnell Sharon Collins | Chief Scientific Officer | Tax Withholding | 11,655 | $1.11 | $12,937 | 332,193 | Aug 16, 2018 |
| KUSSMAN CRAIG | Chief Financial Officer | Tax Withholding | 15,320 | $1.11 | $17,005 | 347,823 | Aug 16, 2018 |
| Gallant Paul | General Manager | Tax Withholding | 9,835 | $1.11 | $10,917 | 229,969 | Aug 16, 2018 |
| CROUCH TAYLOR | CEO & President | Tax Withholding | 5,350 | $1.11 | $5,939 | 169,684 | Aug 16, 2018 |
| Bush Jennifer | General Counsel & Secretary | Tax Withholding | 12,400 | $1.11 | $13,764 | 293,503 | Aug 16, 2018 |
| Hughes Steven George | Chief Medical Officer | Award / Grant | 160,714 | — | — | 160,714 | Aug 14, 2018 |
| CROUCH TAYLOR | CEO & President | Tax Withholding | 15,490 | $1.43 | $22,151 | 175,034 | Jun 22, 2018 |
| Presnell Sharon Collins | Chief Scientific Officer | Award / Grant | 74,380 | — | — | 343,848 | May 24, 2018 |
| KUSSMAN CRAIG | Chief Financial Officer | Award / Grant | 74,380 | — | — | 363,143 | May 24, 2018 |
| Gallant Paul | General Manager | Award / Grant | 66,115 | — | — | 239,804 | May 24, 2018 |
| CROUCH TAYLOR | CEO & President | Award / Grant | 148,760 | — | — | 148,760 | May 24, 2018 |
| Bush Jennifer | General Counsel & Secretary | Award / Grant | 70,248 | — | — | 305,903 | May 24, 2018 |
| Presnell Sharon Collins | Chief Scientific Officer | Tax Withholding | 8,325 | $1.66 | $13,820 | 269,468 | May 16, 2018 |
| KUSSMAN CRAIG | Chief Financial Officer | Tax Withholding | 11,720 | $1.66 | $19,455 | 288,763 | May 16, 2018 |
| Gallant Paul | General Manager | Tax Withholding | 6,890 | $1.66 | $11,437 | 173,689 | May 16, 2018 |
| Bush Jennifer | General Counsel & Secretary | Tax Withholding | 9,160 | $1.66 | $15,206 | 235,655 | May 16, 2018 |
| Presnell Sharon Collins | Chief Scientific Officer | Tax Withholding | 9,420 | $1.09 | $10,268 | 277,793 | Feb 16, 2018 |
| KUSSMAN CRAIG | Chief Financial Officer | Tax Withholding | 13,265 | $1.09 | $14,459 | 300,483 | Feb 16, 2018 |
| Gallant Paul | General Manager | Tax Withholding | 7,820 | $1.09 | $8,524 | 180,579 | Feb 16, 2018 |
| Bush Jennifer | General Counsel & Secretary | Tax Withholding | 10,365 | $1.09 | $11,298 | 244,815 | Feb 16, 2018 |
| Murphy Keith | — | Purchase | 135,000 | $1.50 | $202,500 | 6,173,173 | Nov 24, 2017 |
| Presnell Sharon Collins | Chief Scientific Officer | Tax Withholding | 5,860 | $1.47 | $8,614 | 287,213 | Nov 16, 2017 |
| KUSSMAN CRAIG | Chief Financial Officer | Tax Withholding | 11,890 | $1.47 | $17,478 | 313,748 | Nov 16, 2017 |
| Gallant Paul | General Manager | Tax Withholding | 7,015 | $1.47 | $10,312 | 188,399 | Nov 16, 2017 |
| David Eric | CSO & EVP Pre-Clinical Dev | Tax Withholding | 5,625 | $1.47 | $8,269 | 876,609 | Nov 16, 2017 |
| Bush Jennifer | General Counsel & Secretary | Tax Withholding | 8,900 | $1.47 | $13,083 | 255,180 | Nov 16, 2017 |
| Presnell Sharon Collins | Chief Scientific Officer | Tax Withholding | 6,115 | $2.06 | $12,597 | 293,073 | Aug 16, 2017 |
| KUSSMAN CRAIG | Chief Financial Officer | Tax Withholding | 26,362 | $2.06 | $54,306 | 325,638 | Aug 16, 2017 |
| Gallant Paul | General Manager | Tax Withholding | 7,324 | $2.06 | $15,087 | 195,414 | Aug 16, 2017 |
| David Eric | CSO & EVP Pre-Clinical Dev | Tax Withholding | 8,469 | $2.06 | $17,446 | 882,234 | Aug 16, 2017 |
| Bush Jennifer | General Counsel & Secretary | Tax Withholding | 5,871 | $2.06 | $12,094 | 264,080 | Aug 16, 2017 |
| Presnell Sharon Collins | Chief Scientific Officer | Award / Grant | 200,000 | — | — | 299,188 | Jun 27, 2017 |
| KUSSMAN CRAIG | Chief Financial Officer | Award / Grant | 220,000 | — | — | 352,000 | Jun 27, 2017 |
| Gallant Paul | General Manager | Award / Grant | 160,000 | — | — | 202,738 | Jun 27, 2017 |
| David Eric | CSO & EVP Pre-Clinical Dev | Award / Grant | 190,000 | — | — | 890,703 | Jun 27, 2017 |
| Bush Jennifer | General Counsel & Secretary | Award / Grant | 190,000 | — | — | 269,951 | Jun 27, 2017 |
| Gallant Paul | General Manager | Tax Withholding | 1,317 | $2.86 | $3,767 | 42,738 | May 16, 2017 |
| David Eric | CSO & EVP Pre-Clinical Dev | Tax Withholding | 1,263 | $2.86 | $3,612 | 700,703 | May 16, 2017 |
| Bush Jennifer | General Counsel & Secretary | Tax Withholding | 1,235 | $2.86 | $3,532 | 44,951 | May 16, 2017 |
| Presnell Sharon Collins | Chief Scientific Officer | Tax Withholding | 1,167 | $2.86 | $3,338 | 99,188 | May 16, 2017 |
| Presnell Sharon Collins | Chief Scientific Officer | Gift | 15,000 | — | — | 100,355 | Mar 18, 2017 |
| Presnell Sharon Collins | Chief Scientific Officer | Tax Withholding | 1,390 | $2.95 | $4,101 | 115,355 | Feb 16, 2017 |
| Murphy Keith | Chairman, CEO and President | Tax Withholding | 5,742 | $2.95 | $16,939 | 6,038,173 | Feb 16, 2017 |
| Gallant Paul | General Manager | Tax Withholding | 1,320 | $2.95 | $3,894 | 44,055 | Feb 16, 2017 |
| David Eric | CSO & EVP Pre-Clinical Dev | Tax Withholding | 1,390 | $2.95 | $4,101 | 701,966 | Feb 16, 2017 |
| Bush Jennifer | General Counsel & Secretary | Tax Withholding | 1,390 | $2.95 | $4,101 | 46,186 | Feb 16, 2017 |
| Murphy Keith | — | Gift | 19,000 | — | — | 6,019,173 | Feb 14, 2017 |